Industry Research Reports

Home > Reports > Service & Software > Clinical Trial Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Clinical Trial Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-07-05

Pages: 134 Pages

Report ld: 4784717

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Clinical Trial Imaging Market Size(US$)

CAGR 2025-2031

6.9%

Market Size,2031

USD 2,501

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 1,673 million

Market Forecast in 2031(Value)

US$ 2,501 million

CAGR

6.9%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Clinical Trial Imaging was estimated to be worth US$ 1579 million in 2024 and is forecast to a readjusted size of US$ 2501 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.

Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.

The core manufacturers of clinical trial imaging in the world include Clario, ICON, McLaren, Calyx and BioTelemetry. The top five companies hold about 60% of the shares. North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, each with a share of about 27%. In terms of product type, central imaging services are the largest market segment, with a share of about 70%. In terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of subjects are fully guaranteed and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of trial results.

Clinical trial imaging plays an important role in different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.

For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.

In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and evaluation of treatment effects. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.

With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.

The driving factors of the clinical trial imaging market mainly include the following:

Technological progress: innovation drives core growth

High-precision and multimodal imaging technology

Breakthroughs in technologies such as MRI, CT, and PET: High-resolution imaging technology (such as 3T MRI and ultra-low-dose CT) provides more accurate anatomical and functional information, which helps early diagnosis of diseases and efficacy evaluation.

Multimodal fusion: The fusion technology of CT and MRI, PET and CT, combined with anatomical and metabolic information, significantly improves diagnostic sensitivity, such as in tumor staging.

Artificial Intelligence and Automation

AI-assisted analysis: Deep learning algorithms can automatically detect lesions (such as lung nodules and breast calcifications), reduce human errors, and improve diagnostic efficiency.

Process Automation: AI optimizes scanning protocols and automatically generates reports, shortens clinical trial cycles, and reduces costs.

Portable and Real-time Imaging

Portable ultrasound equipment: Suitable for bedside examinations and remote areas, expanding the coverage of clinical trials.

Real-time imaging technology: such as ultrasound elastic imaging, dynamically monitors changes in tissue hardness, and provides instant feedback for diseases such as liver fibrosis.

Policy support: Create a favorable development environment

Improvement of regulatory framework

FDA, NMPA and other agencies: Ensure the safety and effectiveness of equipment through strict approval processes, such as requiring that Class III medical imaging equipment must pass clinical trials before registration.

International Standard Coordination: Promote imaging protocols and data standardization (such as DICOM format) and promote multi-center trial data sharing.

Funding and Incentives

Government research funding: For example, China's "14th Five-Year Plan" special support for medical imaging technology to accelerate technology transformation.

Tax incentives and subsidies: Encourage corporate R&D and innovation, such as providing financial subsidies for localization projects of high-end imaging equipment.

Growth in medical demand: changes in population and disease structure

Aging and chronic disease burden

High incidence of cancer and neurodegenerative diseases: The global incidence of cancer is rising, driving the demand for early screening and efficacy monitoring.

Demand for precision medicine: Individualized treatment relies on high-precision imaging (such as molecular imaging in tumor targeted therapy).

New drug development and clinical trial expansion

Innovative drug development boom: The number of new drugs under development has surged globally, and the demand for imaging in clinical trials has increased accordingly.

Rare diseases and real-world research: Imaging technology helps small sample size trials and long-term efficacy tracking.

The growth of the clinical trial imaging market is the result of technological innovation, policy dividends, demand upgrades and the evolution of the competitive landscape. In the future, with the deep integration of AI, multimodal imaging and cloud technology, the market will accelerate its development towards intelligence and precision. At the same time, the rise of local companies will reshape the global competitive landscape and inject new vitality into the industry.

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Imaging by region & country, by Type, and by Application.

The Clinical Trial Imaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging.

MARKET SEGMENTATION

By Company

ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Tigermed
Runda Medical
Konica Minolta
Keosys

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

In-house Imaging Service
Central Imaging Service

Segment by Application

Pharmaceutical Companies
Biotechnology Companies
Academic Institutes
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Clinical Trial Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Clinical Trial Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Clinical Trial Imaging in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Clinical Trial Imaging Product Introduction

1.2 Global Clinical Trial Imaging Market Size Forecast (2020-2031)

1.3 Clinical Trial Imaging Market Trends & Drivers

1.3.1 Clinical Trial Imaging Industry Trends

1.3.2 Clinical Trial Imaging Market Drivers & Opportunity

1.3.3 Clinical Trial Imaging Market Challenges

1.3.4 Clinical Trial Imaging Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Clinical Trial Imaging Players Revenue Ranking (2024)

2.2 Global Clinical Trial Imaging Revenue by Company (2020-2025)

2.3 Key Companies Clinical Trial Imaging Manufacturing Base Distribution and Headquarters

2.4 Key Companies Clinical Trial Imaging Product Offered

2.5 Key Companies Time to Begin Mass Production of Clinical Trial Imaging

2.6 Clinical Trial Imaging Market Competitive Analysis

2.6.1 Clinical Trial Imaging Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Imaging Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 In-house Imaging Service

3.1.2 Central Imaging Service

3.2 Global Clinical Trial Imaging Sales Value by Type

3.2.1 Global Clinical Trial Imaging Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Clinical Trial Imaging Sales Value, by Type (2020-2031)

3.2.3 Global Clinical Trial Imaging Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pharmaceutical Companies

4.1.2 Biotechnology Companies

4.1.3 Academic Institutes

4.1.4 Others

4.2 Global Clinical Trial Imaging Sales Value by Application

4.2.1 Global Clinical Trial Imaging Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Clinical Trial Imaging Sales Value, by Application (2020-2031)

4.2.3 Global Clinical Trial Imaging Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Clinical Trial Imaging Sales Value by Region

5.1.1 Global Clinical Trial Imaging Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Clinical Trial Imaging Sales Value by Region (2020-2025)

5.1.3 Global Clinical Trial Imaging Sales Value by Region (2026-2031)

5.1.4 Global Clinical Trial Imaging Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Clinical Trial Imaging Sales Value, 2020-2031

5.2.2 North America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Clinical Trial Imaging Sales Value, 2020-2031

5.3.2 Europe Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Clinical Trial Imaging Sales Value, 2020-2031

5.4.2 Asia Pacific Clinical Trial Imaging Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Clinical Trial Imaging Sales Value, 2020-2031

5.5.2 South America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Clinical Trial Imaging Sales Value, 2020-2031

5.6.2 Middle East & Africa Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Clinical Trial Imaging Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Clinical Trial Imaging Sales Value, 2020-2031

6.3 United States

6.3.1 United States Clinical Trial Imaging Sales Value, 2020-2031

6.3.2 United States Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Clinical Trial Imaging Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Clinical Trial Imaging Sales Value, 2020-2031

6.4.2 Europe Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Clinical Trial Imaging Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Clinical Trial Imaging Sales Value, 2020-2031

6.5.2 China Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

6.5.3 China Clinical Trial Imaging Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Clinical Trial Imaging Sales Value, 2020-2031

6.6.2 Japan Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Clinical Trial Imaging Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Clinical Trial Imaging Sales Value, 2020-2031

6.7.2 South Korea Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Clinical Trial Imaging Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Clinical Trial Imaging Sales Value, 2020-2031

6.8.2 Southeast Asia Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Clinical Trial Imaging Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Clinical Trial Imaging Sales Value, 2020-2031

6.9.2 India Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

6.9.3 India Clinical Trial Imaging Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 ICON

7.1.1 ICON Profile

7.1.2 ICON Main Business

7.1.3 ICON Clinical Trial Imaging Products, Services and Solutions

7.1.4 ICON Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.1.5 ICON Recent Developments

7.2 ERT

7.2.1 ERT Profile

7.2.2 ERT Main Business

7.2.3 ERT Clinical Trial Imaging Products, Services and Solutions

7.2.4 ERT Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.2.5 ERT Recent Developments

7.3 McLaren

7.3.1 McLaren Profile

7.3.2 McLaren Main Business

7.3.3 McLaren Clinical Trial Imaging Products, Services and Solutions

7.3.4 McLaren Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.3.5 McLaren Recent Developments

7.4 Bioclinica

7.4.1 Bioclinica Profile

7.4.2 Bioclinica Main Business

7.4.3 Bioclinica Clinical Trial Imaging Products, Services and Solutions

7.4.4 Bioclinica Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.4.5 Bioclinica Recent Developments

7.5 Parexel

7.5.1 Parexel Profile

7.5.2 Parexel Main Business

7.5.3 Parexel Clinical Trial Imaging Products, Services and Solutions

7.5.4 Parexel Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.5.5 Parexel Recent Developments

7.6 BioTelemetry

7.6.1 BioTelemetry Profile

7.6.2 BioTelemetry Main Business

7.6.3 BioTelemetry Clinical Trial Imaging Products, Services and Solutions

7.6.4 BioTelemetry Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.6.5 BioTelemetry Recent Developments

7.7 ProScan Imaging

7.7.1 ProScan Imaging Profile

7.7.2 ProScan Imaging Main Business

7.7.3 ProScan Imaging Clinical Trial Imaging Products, Services and Solutions

7.7.4 ProScan Imaging Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.7.5 ProScan Imaging Recent Developments

7.8 Imaging Endpoints

7.8.1 Imaging Endpoints Profile

7.8.2 Imaging Endpoints Main Business

7.8.3 Imaging Endpoints Clinical Trial Imaging Products, Services and Solutions

7.8.4 Imaging Endpoints Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.8.5 Imaging Endpoints Recent Developments

7.9 Radiant Sage

7.9.1 Radiant Sage Profile

7.9.2 Radiant Sage Main Business

7.9.3 Radiant Sage Clinical Trial Imaging Products, Services and Solutions

7.9.4 Radiant Sage Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.9.5 Radiant Sage Recent Developments

7.10 Micron, Inc.

7.10.1 Micron, Inc. Profile

7.10.2 Micron, Inc. Main Business

7.10.3 Micron, Inc. Clinical Trial Imaging Products, Services and Solutions

7.10.4 Micron, Inc. Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.10.5 Micron, Inc. Recent Developments

7.11 Intrinsic Imaging

7.11.1 Intrinsic Imaging Profile

7.11.2 Intrinsic Imaging Main Business

7.11.3 Intrinsic Imaging Clinical Trial Imaging Products, Services and Solutions

7.11.4 Intrinsic Imaging Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.11.5 Intrinsic Imaging Recent Developments

7.12 Median Technologies

7.12.1 Median Technologies Profile

7.12.2 Median Technologies Main Business

7.12.3 Median Technologies Clinical Trial Imaging Products, Services and Solutions

7.12.4 Median Technologies Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.12.5 Median Technologies Recent Developments

7.13 Cardiovascular Imaging Technologies

7.13.1 Cardiovascular Imaging Technologies Profile

7.13.2 Cardiovascular Imaging Technologies Main Business

7.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Products, Services and Solutions

7.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.13.5 Cardiovascular Imaging Technologies Recent Developments

7.14 Banook Medical

7.14.1 Banook Medical Profile

7.14.2 Banook Medical Main Business

7.14.3 Banook Medical Clinical Trial Imaging Products, Services and Solutions

7.14.4 Banook Medical Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.14.5 Banook Medical Recent Developments

7.15 IXICO

7.15.1 IXICO Profile

7.15.2 IXICO Main Business

7.15.3 IXICO Clinical Trial Imaging Products, Services and Solutions

7.15.4 IXICO Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.15.5 IXICO Recent Developments

7.16 Tigermed

7.16.1 Tigermed Profile

7.16.2 Tigermed Main Business

7.16.3 Tigermed Clinical Trial Imaging Products, Services and Solutions

7.16.4 Tigermed Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.16.5 Tigermed Recent Developments

7.17 Runda Medical

7.17.1 Runda Medical Profile

7.17.2 Runda Medical Main Business

7.17.3 Runda Medical Clinical Trial Imaging Products, Services and Solutions

7.17.4 Runda Medical Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.17.5 Runda Medical Recent Developments

7.18 Konica Minolta

7.18.1 Konica Minolta Profile

7.18.2 Konica Minolta Main Business

7.18.3 Konica Minolta Clinical Trial Imaging Products, Services and Solutions

7.18.4 Konica Minolta Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.18.5 Konica Minolta Recent Developments

7.19 Keosys

7.19.1 Keosys Profile

7.19.2 Keosys Main Business

7.19.3 Keosys Clinical Trial Imaging Products, Services and Solutions

7.19.4 Keosys Clinical Trial Imaging Revenue (US$ Million) & (2020-2025)

7.19.5 Keosys Recent Developments

8 Industry Chain Analysis

8.1 Clinical Trial Imaging Industrial Chain

8.2 Clinical Trial Imaging Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Clinical Trial Imaging Sales Model

8.5.2 Sales Channel

8.5.3 Clinical Trial Imaging Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Clinical Trial Imaging Market Trends

Table 2. Clinical Trial Imaging Market Drivers & Opportunity

Table 3. Clinical Trial Imaging Market Challenges

Table 4. Clinical Trial Imaging Market Restraints

Table 5. Global Clinical Trial Imaging Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Clinical Trial Imaging Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Clinical Trial Imaging Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Clinical Trial Imaging Product Type

Table 9. Key Companies Time to Begin Mass Production of Clinical Trial Imaging

Table 10. Global Clinical Trial Imaging Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Clinical Trial Imaging Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Clinical Trial Imaging Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Clinical Trial Imaging Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Clinical Trial Imaging Sales Market Share in Value by Type (2020-2025)

Table 17. Global Clinical Trial Imaging Sales Market Share in Value by Type (2026-2031)

Table 18. Global Clinical Trial Imaging Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Clinical Trial Imaging Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Clinical Trial Imaging Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Clinical Trial Imaging Sales Market Share in Value by Application (2020-2025)

Table 22. Global Clinical Trial Imaging Sales Market Share in Value by Application (2026-2031)

Table 23. Global Clinical Trial Imaging Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Clinical Trial Imaging Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Clinical Trial Imaging Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Clinical Trial Imaging Sales Value by Region (2020-2025) & (%)

Table 27. Global Clinical Trial Imaging Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Clinical Trial Imaging Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Clinical Trial Imaging Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Clinical Trial Imaging Sales Value, (2026-2031) & (US$ Million)

Table 31. ICON Basic Information List

Table 32. ICON Description and Business Overview

Table 33. ICON Clinical Trial Imaging Products, Services and Solutions

Table 34. Revenue (US$ Million) in Clinical Trial Imaging Business of ICON (2020-2025)

Table 35. ICON Recent Developments

Table 36. ERT Basic Information List

Table 37. ERT Description and Business Overview

Table 38. ERT Clinical Trial Imaging Products, Services and Solutions

Table 39. Revenue (US$ Million) in Clinical Trial Imaging Business of ERT (2020-2025)

Table 40. ERT Recent Developments

Table 41. McLaren Basic Information List

Table 42. McLaren Description and Business Overview

Table 43. McLaren Clinical Trial Imaging Products, Services and Solutions

Table 44. Revenue (US$ Million) in Clinical Trial Imaging Business of McLaren (2020-2025)

Table 45. McLaren Recent Developments

Table 46. Bioclinica Basic Information List

Table 47. Bioclinica Description and Business Overview

Table 48. Bioclinica Clinical Trial Imaging Products, Services and Solutions

Table 49. Revenue (US$ Million) in Clinical Trial Imaging Business of Bioclinica (2020-2025)

Table 50. Bioclinica Recent Developments

Table 51. Parexel Basic Information List

Table 52. Parexel Description and Business Overview

Table 53. Parexel Clinical Trial Imaging Products, Services and Solutions

Table 54. Revenue (US$ Million) in Clinical Trial Imaging Business of Parexel (2020-2025)

Table 55. Parexel Recent Developments

Table 56. BioTelemetry Basic Information List

Table 57. BioTelemetry Description and Business Overview

Table 58. BioTelemetry Clinical Trial Imaging Products, Services and Solutions

Table 59. Revenue (US$ Million) in Clinical Trial Imaging Business of BioTelemetry (2020-2025)

Table 60. BioTelemetry Recent Developments

Table 61. ProScan Imaging Basic Information List

Table 62. ProScan Imaging Description and Business Overview

Table 63. ProScan Imaging Clinical Trial Imaging Products, Services and Solutions

Table 64. Revenue (US$ Million) in Clinical Trial Imaging Business of ProScan Imaging (2020-2025)

Table 65. ProScan Imaging Recent Developments

Table 66. Imaging Endpoints Basic Information List

Table 67. Imaging Endpoints Description and Business Overview

Table 68. Imaging Endpoints Clinical Trial Imaging Products, Services and Solutions

Table 69. Revenue (US$ Million) in Clinical Trial Imaging Business of Imaging Endpoints (2020-2025)

Table 70. Imaging Endpoints Recent Developments

Table 71. Radiant Sage Basic Information List

Table 72. Radiant Sage Description and Business Overview

Table 73. Radiant Sage Clinical Trial Imaging Products, Services and Solutions

Table 74. Revenue (US$ Million) in Clinical Trial Imaging Business of Radiant Sage (2020-2025)

Table 75. Radiant Sage Recent Developments

Table 76. Micron, Inc. Basic Information List

Table 77. Micron, Inc. Description and Business Overview

Table 78. Micron, Inc. Clinical Trial Imaging Products, Services and Solutions

Table 79. Revenue (US$ Million) in Clinical Trial Imaging Business of Micron, Inc. (2020-2025)

Table 80. Micron, Inc. Recent Developments

Table 81. Intrinsic Imaging Basic Information List

Table 82. Intrinsic Imaging Description and Business Overview

Table 83. Intrinsic Imaging Clinical Trial Imaging Products, Services and Solutions

Table 84. Revenue (US$ Million) in Clinical Trial Imaging Business of Intrinsic Imaging (2020-2025)

Table 85. Intrinsic Imaging Recent Developments

Table 86. Median Technologies Basic Information List

Table 87. Median Technologies Description and Business Overview

Table 88. Median Technologies Clinical Trial Imaging Products, Services and Solutions

Table 89. Revenue (US$ Million) in Clinical Trial Imaging Business of Median Technologies (2020-2025)

Table 90. Median Technologies Recent Developments

Table 91. Cardiovascular Imaging Technologies Basic Information List

Table 92. Cardiovascular Imaging Technologies Description and Business Overview

Table 93. Cardiovascular Imaging Technologies Clinical Trial Imaging Products, Services and Solutions

Table 94. Revenue (US$ Million) in Clinical Trial Imaging Business of Cardiovascular Imaging Technologies (2020-2025)

Table 95. Cardiovascular Imaging Technologies Recent Developments

Table 96. Banook Medical Basic Information List

Table 97. Banook Medical Description and Business Overview

Table 98. Banook Medical Clinical Trial Imaging Products, Services and Solutions

Table 99. Revenue (US$ Million) in Clinical Trial Imaging Business of Banook Medical (2020-2025)

Table 100. Banook Medical Recent Developments

Table 101. IXICO Basic Information List

Table 102. IXICO Description and Business Overview

Table 103. IXICO Clinical Trial Imaging Products, Services and Solutions

Table 104. Revenue (US$ Million) in Clinical Trial Imaging Business of IXICO (2020-2025)

Table 105. IXICO Recent Developments

Table 106. Tigermed Basic Information List

Table 107. Tigermed Description and Business Overview

Table 108. Tigermed Clinical Trial Imaging Products, Services and Solutions

Table 109. Revenue (US$ Million) in Clinical Trial Imaging Business of Tigermed (2020-2025)

Table 110. Tigermed Recent Developments

Table 111. Runda Medical Basic Information List

Table 112. Runda Medical Description and Business Overview

Table 113. Runda Medical Clinical Trial Imaging Products, Services and Solutions

Table 114. Revenue (US$ Million) in Clinical Trial Imaging Business of Runda Medical (2020-2025)

Table 115. Runda Medical Recent Developments

Table 116. Konica Minolta Basic Information List

Table 117. Konica Minolta Description and Business Overview

Table 118. Konica Minolta Clinical Trial Imaging Products, Services and Solutions

Table 119. Revenue (US$ Million) in Clinical Trial Imaging Business of Konica Minolta (2020-2025)

Table 120. Konica Minolta Recent Developments

Table 121. Keosys Basic Information List

Table 122. Keosys Description and Business Overview

Table 123. Keosys Clinical Trial Imaging Products, Services and Solutions

Table 124. Revenue (US$ Million) in Clinical Trial Imaging Business of Keosys (2020-2025)

Table 125. Keosys Recent Developments

Table 126. Key Raw Materials Lists

Table 127. Raw Materials Key Suppliers Lists

Table 128. Clinical Trial Imaging Downstream Customers

Table 129. Clinical Trial Imaging Distributors List

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Clinical Trial Imaging Product Picture

Figure 2. Global Clinical Trial Imaging Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Clinical Trial Imaging Sales Value (2020-2031) & (US$ Million)

Figure 4. Clinical Trial Imaging Report Years Considered

Figure 5. Global Clinical Trial Imaging Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Clinical Trial Imaging Revenue in 2024

Figure 7. Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. In-house Imaging Service Picture

Figure 9. Central Imaging Service Picture

Figure 10. Global Clinical Trial Imaging Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Clinical Trial Imaging Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Pharmaceutical Companies

Figure 13. Product Picture of Biotechnology Companies

Figure 14. Product Picture of Academic Institutes

Figure 15. Product Picture of Others

Figure 16. Global Clinical Trial Imaging Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 17. Global Clinical Trial Imaging Sales Value Market Share by Application, 2024 & 2031

Figure 18. North America Clinical Trial Imaging Sales Value (2020-2031) & (US$ Million)

Figure 19. North America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031

Figure 20. Europe Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 21. Europe Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031

Figure 22. Asia Pacific Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 23. Asia Pacific Clinical Trial Imaging Sales Value by Region (%), 2024 VS 2031

Figure 24. South America Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 25. South America Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031

Figure 26. Middle East & Africa Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 27. Middle East & Africa Clinical Trial Imaging Sales Value by Country (%), 2024 VS 2031

Figure 28. Key Countries/Regions Clinical Trial Imaging Sales Value (%), (2020-2031)

Figure 29. United States Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 30. United States Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

Figure 31. United States Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031

Figure 32. Europe Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 33. Europe Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

Figure 34. Europe Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031

Figure 35. China Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 36. China Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

Figure 37. China Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031

Figure 38. Japan Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 39. Japan Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

Figure 40. Japan Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031

Figure 41. South Korea Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 42. South Korea Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

Figure 43. South Korea Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031

Figure 44. Southeast Asia Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

Figure 46. Southeast Asia Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031

Figure 47. India Clinical Trial Imaging Sales Value, (2020-2031) & (US$ Million)

Figure 48. India Clinical Trial Imaging Sales Value by Type (%), 2024 VS 2031

Figure 49. India Clinical Trial Imaging Sales Value by Application (%), 2024 VS 2031

Figure 50. Clinical Trial Imaging Industrial Chain

Figure 51. Clinical Trial Imaging Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Clinical Trial Imaging in 2031? zhanKai

The global market size of Clinical Trial Imaging in 2031 was 2501 Million USD.

What was the global market size of Clinical Trial Imaging in 2025? shouQi

Which companies rank high in the global Clinical Trial Imaging market? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Clinical Trial Imaging market size from 2025 to 2031? shouQi

Related Reports

Global Clinical Trial Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Clinical Trial Imaging market size was US$ 1673 million in 2025 and is forecast to reach a readjusted size of US$ 2657 million by 2032 with a CAGR of 6.9% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 106
USD 4250.00
(Single User License)
Global Clinical Trial Imaging Market Research Report 2026
The global Clinical Trial Imaging market was valued at US$ 1673 million in 2025 and is anticipated to reach US$ 2657 million by 2032, at a CAGR of 6.9% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 122
USD 2900.00
(Single User License)
Clinical Trial Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Clinical Trial Imaging was estimated to be worth US$ 1673 million in 2025 and is projected to reach US$ 2657 million, growing at a CAGR of 6.9% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 140
USD 3950.00
(Single User License)
Global Clinical Trial Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Clinical Trial Imaging market size was US$ 1579 million in 2024 and is forecast to a readjusted size of US$ 2501 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 102
USD 4250.00
(Single User License)
Global Clinical Trial Imaging Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Clinical Trial Imaging market is projected to grow from US$ 1579 million in 2024 to US$ 2501 million by 2031, at a CAGR of 6.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-08
Pages: 156
USD 4900.00
(Single User License)
Global Clinical Trial Imaging Market Insights, Forecast to 2031
The global Clinical Trial Imaging market is projected to grow from US$ 1673 million in 2025 to US$ 2501 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.
Published Date: 2025-07-05
Pages: 151
USD 4900.00
(Single User License)
Global Clinical Trial Imaging Market Research Report 2025
The global market for Clinical Trial Imaging was valued at US$ 1579 million in the year 2024 and is projected to reach a revised size of US$ 2501 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published Date: 2025-07-05
Pages: 99
USD 2900.00
(Single User License)
Global Clinical Trial Imaging Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Clinical Trial Imaging was estimated to be worth US$ 1569 million and is forecast to reach approximately US$ 2492 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 157
USD 5900.00
(Single User License)
Clinical Trial Imaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Clinical Trial Imaging was estimated to be worth US$ 1569 million in 2024 and is forecast to a readjusted size of US$ 2492 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 121
USD 3950.00
(Single User License)
Global and United States Clinical Trial Imaging Market Report & Forecast 2024-2030
Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.
Published Date: 2024-09-26
Pages: 133
USD 4350.00
(Single User License)

Global Clinical Trial Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Clinical Trial Imaging market size was US$ 1673 million in 2025 and is forecast to reach a readjusted size of US$ 2657 million by 2032 with a CAGR of 6.9% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 106
USD 4250.00 (Single User License)
Global Clinical Trial Imaging Market Research Report 2026
The global Clinical Trial Imaging market was valued at US$ 1673 million in 2025 and is anticipated to reach US$ 2657 million by 2032, at a CAGR of 6.9% from 2026 to 2032.
Published: 2026-01-04
Pages: 122
USD 2900.00 (Single User License)
Clinical Trial Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Clinical Trial Imaging was estimated to be worth US$ 1673 million in 2025 and is projected to reach US$ 2657 million, growing at a CAGR of 6.9% from 2026 to 2032.
Published: 2026-01-04
Pages: 140
USD 3950.00 (Single User License)
Global Clinical Trial Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Clinical Trial Imaging market size was US$ 1579 million in 2024 and is forecast to a readjusted size of US$ 2501 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 102
USD 4250.00 (Single User License)
Global Clinical Trial Imaging Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Clinical Trial Imaging market is projected to grow from US$ 1579 million in 2024 to US$ 2501 million by 2031, at a CAGR of 6.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-08
Pages: 156
USD 4900.00 (Single User License)
Global Clinical Trial Imaging Market Insights, Forecast to 2031
The global Clinical Trial Imaging market is projected to grow from US$ 1673 million in 2025 to US$ 2501 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.
Published: 2025-07-05
Pages: 151
USD 4900.00 (Single User License)
Global Clinical Trial Imaging Market Research Report 2025
The global market for Clinical Trial Imaging was valued at US$ 1579 million in the year 2024 and is projected to reach a revised size of US$ 2501 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published: 2025-07-05
Pages: 99
USD 2900.00 (Single User License)
Global Clinical Trial Imaging Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Clinical Trial Imaging was estimated to be worth US$ 1569 million and is forecast to reach approximately US$ 2492 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 157
USD 5900.00 (Single User License)
Clinical Trial Imaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Clinical Trial Imaging was estimated to be worth US$ 1569 million in 2024 and is forecast to a readjusted size of US$ 2492 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 121
USD 3950.00 (Single User License)
Global and United States Clinical Trial Imaging Market Report & Forecast 2024-2030
Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.
Published: 2024-09-26
Pages: 133
USD 4350.00 (Single User License)